المؤلفون: Gourdy, Pierre, Darmon, Patrice, Dievart, François, Halimi, Jean-Michel, Guerci, Bruno

المساهمون: Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)

المصدر: ISSN: 1475-2840 ; Cardiovascular Diabetology ; https://amu.hal.science/hal-04395593Test ; Cardiovascular Diabetology, 2023, 22 (1), pp.79. ⟨10.1186/s12933-023-01798-4⟩.

مصطلحات موضوعية: Glucagon-like peptide-1 receptor agonists, Sodium-glucose cotransporter-2 inhibitors, Type 2 diabetes mellitus, Combination therapy, Cardiovascular protection, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37005640; hal-04395593; https://amu.hal.science/hal-04395593Test; https://amu.hal.science/hal-04395593/documentTest; https://amu.hal.science/hal-04395593/file/s12933-023-01798-4.pdfTest; PUBMED: 37005640; WOS: 000961475800002

الإتاحة: https://doi.org/10.1186/s12933-023-01798-4Test
https://amu.hal.science/hal-04395593Test
https://amu.hal.science/hal-04395593/documentTest
https://amu.hal.science/hal-04395593/file/s12933-023-01798-4.pdfTest

المؤلفون: Gourdy, Pierre, Darmon, Patrice, Dievart, François, Halimi, Jean-Michel, Guerci, Bruno

المساهمون: Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)

المصدر: ISSN: 1475-2840 ; Cardiovascular Diabetology ; https://amu.hal.science/hal-04395593Test ; Cardiovascular Diabetology, 2023, 22 (1), pp.79. ⟨10.1186/s12933-023-01798-4⟩.

مصطلحات موضوعية: Glucagon-like peptide-1 receptor agonists, Sodium-glucose cotransporter-2 inhibitors, Type 2 diabetes mellitus, Combination therapy, Cardiovascular protection, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37005640; hal-04395593; https://amu.hal.science/hal-04395593Test; https://amu.hal.science/hal-04395593/documentTest; https://amu.hal.science/hal-04395593/file/s12933-023-01798-4.pdfTest; PUBMED: 37005640; WOS: 000961475800002

الإتاحة: https://doi.org/10.1186/s12933-023-01798-4Test
https://amu.hal.science/hal-04395593Test
https://amu.hal.science/hal-04395593/documentTest
https://amu.hal.science/hal-04395593/file/s12933-023-01798-4.pdfTest

المؤلفون: Mosenzon, Ofri, Alguwaihes, Abdullah, Leon, Jose Luis Arenas, Bayram, Fahri, Darmon, Patrice, Davis, Timothy, Dieuzeide, Guillermo, Eriksen, Kirsten, Hong, Tianpei, Kaltoft, Margit, Lengyel, Csaba, Rhee, Nicolai, Russo, Giuseppina, Shirabe, Shinichiro, Urbancova, Katerina, Vencio, Sergio

المساهمون: The Hebrew University of Jerusalem (HUJ), King Saud University Riyadh (KSU), Erciyes University, Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), The University of Western Australia (UWA), Novo Nordisk Inc, NOVO NORDISK PARK, Peking University Beijing, University of Szeged Szeged, Novo nordisk pharma, University of Messina

المصدر: ISSN: 1475-2840 ; Cardiovascular Diabetology ; https://amu.hal.science/hal-03653398Test ; Cardiovascular Diabetology, 2021, 20 (1), pp.154. ⟨10.1186/s12933-021-01344-0⟩.

مصطلحات موضوعية: Cardiovascular disease, Glucagon-like peptide-1 receptor agonists, Non-interventional study, Prevalence, Sodium-glucose co-transporter-2 inhibitors, Type 2 diabetes, Atherosclerotic cardiovascular disease, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34315481; hal-03653398; https://amu.hal.science/hal-03653398Test; https://amu.hal.science/hal-03653398/documentTest; https://amu.hal.science/hal-03653398/file/12933_2021_Article_1344.pdfTest; PUBMED: 34315481; PUBMEDCENTRAL: PMC8317423; WOS: 000678653700004

الإتاحة: https://doi.org/10.1186/s12933-021-01344-0Test
https://amu.hal.science/hal-03653398Test
https://amu.hal.science/hal-03653398/documentTest
https://amu.hal.science/hal-03653398/file/12933_2021_Article_1344.pdfTest

المؤلفون: Mosenzon, Ofri, Alguwaihes, Abdullah, Leon, Jose Luis Arenas, Bayram, Fahri, Darmon, Patrice, Davis, Timothy, Dieuzeide, Guillermo, Eriksen, Kirsten, Hong, Tianpei, Kaltoft, Margit, Lengyel, Csaba, Rhee, Nicolai, Russo, Giuseppina, Shirabe, Shinichiro, Urbancova, Katerina, Vencio, Sergio

المساهمون: The Hebrew University of Jerusalem (HUJ), King Saud University Riyadh (KSU), Erciyes University, Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), The University of Western Australia (UWA), Novo Nordisk Inc, NOVO NORDISK PARK, Peking University Beijing, University of Szeged Szeged, Novo nordisk pharma, University of Messina

المصدر: ISSN: 1475-2840 ; Cardiovascular Diabetology ; https://amu.hal.science/hal-03653398Test ; Cardiovascular Diabetology, 2021, 20 (1), pp.154. ⟨10.1186/s12933-021-01344-0⟩.

مصطلحات موضوعية: Cardiovascular disease, Glucagon-like peptide-1 receptor agonists, Non-interventional study, Prevalence, Sodium-glucose co-transporter-2 inhibitors, Type 2 diabetes, Atherosclerotic cardiovascular disease, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34315481; hal-03653398; https://amu.hal.science/hal-03653398Test; https://amu.hal.science/hal-03653398/documentTest; https://amu.hal.science/hal-03653398/file/12933_2021_Article_1344.pdfTest; PUBMED: 34315481; PUBMEDCENTRAL: PMC8317423; WOS: 000678653700004

الإتاحة: https://doi.org/10.1186/s12933-021-01344-0Test
https://amu.hal.science/hal-03653398Test
https://amu.hal.science/hal-03653398/documentTest
https://amu.hal.science/hal-03653398/file/12933_2021_Article_1344.pdfTest

المؤلفون: Mosenzon, Ofri, Alguwaihes, Abdullah, Leon, Jose Luis Arenas, Bayram, Fahri, Darmon, Patrice, Davis, Timothy, Dieuzeide, Guillermo, Eriksen, Kirsten, Hong, Tianpei, Kaltoft, Margit, Lengyel, Csaba, Rhee, Nicolai, Russo, Giuseppina, Shirabe, Shinichiro, Urbancova, Katerina, Vencio, Sergio

المساهمون: The Hebrew University of Jerusalem (HUJ), King Saud University Riyadh (KSU), Erciyes University, Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), The University of Western Australia (UWA), Novo Nordisk Inc, NOVO NORDISK PARK, Peking University Beijing, University of Szeged Szeged, Novo nordisk pharma, University of Messina

المصدر: ISSN: 1475-2840 ; Cardiovascular Diabetology ; https://amu.hal.science/hal-03653398Test ; Cardiovascular Diabetology, 2021, 20 (1), pp.154. ⟨10.1186/s12933-021-01344-0⟩.

مصطلحات موضوعية: Cardiovascular disease, Glucagon-like peptide-1 receptor agonists, Non-interventional study, Prevalence, Sodium-glucose co-transporter-2 inhibitors, Type 2 diabetes, Atherosclerotic cardiovascular disease, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34315481; hal-03653398; https://amu.hal.science/hal-03653398Test; https://amu.hal.science/hal-03653398/documentTest; https://amu.hal.science/hal-03653398/file/12933_2021_Article_1344.pdfTest; PUBMED: 34315481; PUBMEDCENTRAL: PMC8317423; WOS: 000678653700004

الإتاحة: https://doi.org/10.1186/s12933-021-01344-0Test
https://amu.hal.science/hal-03653398Test
https://amu.hal.science/hal-03653398/documentTest
https://amu.hal.science/hal-03653398/file/12933_2021_Article_1344.pdfTest

المؤلفون: Ferreira, João Pedro, Sharma, Abhinav, Butler, Javed, Packer, Milton, Zannad, Faiez, Vasques-Nóvoa, Francisco, Leite-Moreira, Adelino, Neves, João Sérgio

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), Heart Failure Clinic, Centro Hospitalar de Vila Nova de Gaia/Espinho, Faculdade de Medicina da Universidade do Porto (FMUP), Universidade do Porto = University of Porto, McGill University = Université McGill Montréal, Canada, Baylor Scott & White Research Institute (BSWRI), Baylor College of Medecine, Imperial College London, Hospital de São João Porto, This work was financed by national funds through FCT (Fundação para a Ciência e Tecnologia), I.P., within the scope of the Cardiovascular R&D Center (UIDB/00051/2020 and UIDP/00051/2020) and RISE (LA/P/0053/2020).

المصدر: ISSN: 0021-972X.

مصطلحات موضوعية: Glucagon-like peptide-1 receptor agonists, Heart failure, Risk modification, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37409733; hal-04157665; https://hal.univ-lorraine.fr/hal-04157665Test; https://hal.univ-lorraine.fr/hal-04157665/documentTest; https://hal.univ-lorraine.fr/hal-04157665/file/GLP1RA_HF_risk.pdfTest; PUBMED: 37409733

الإتاحة: https://doi.org/10.1210/clinem/dgad398Test
https://hal.univ-lorraine.fr/hal-04157665Test
https://hal.univ-lorraine.fr/hal-04157665/documentTest
https://hal.univ-lorraine.fr/hal-04157665/file/GLP1RA_HF_risk.pdfTest

المؤلفون: Ferreira, João Pedro, Sharma, Abhinav, Butler, Javed, Packer, Milton, Zannad, Faiez, Vasques-Nóvoa, Francisco, Leite-Moreira, Adelino, Neves, João Sérgio

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), Heart Failure Clinic, Centro Hospitalar de Vila Nova de Gaia/Espinho, Faculdade de Medicina da Universidade do Porto (FMUP), Universidade do Porto = University of Porto, McGill University = Université McGill Montréal, Canada, Baylor Scott & White Research Institute (BSWRI), Baylor College of Medecine, Imperial College London, Hospital de São João Porto, This work was financed by national funds through FCT (Fundação para a Ciência e Tecnologia), I.P., within the scope of the Cardiovascular R&D Center (UIDB/00051/2020 and UIDP/00051/2020) and RISE (LA/P/0053/2020).

المصدر: ISSN: 0021-972X.

مصطلحات موضوعية: Glucagon-like peptide-1 receptor agonists, Heart failure, Risk modification, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37409733; hal-04157665; https://hal.univ-lorraine.fr/hal-04157665Test; https://hal.univ-lorraine.fr/hal-04157665/documentTest; https://hal.univ-lorraine.fr/hal-04157665/file/GLP1RA_HF_risk.pdfTest; PUBMED: 37409733

الإتاحة: https://doi.org/10.1210/clinem/dgad398Test
https://hal.univ-lorraine.fr/hal-04157665Test
https://hal.univ-lorraine.fr/hal-04157665/documentTest
https://hal.univ-lorraine.fr/hal-04157665/file/GLP1RA_HF_risk.pdfTest

المؤلفون: Bezin, Julien, Gouverneur, Amandine, Penichon, Marine, Mathieu, Clement, Garrel, Renaud, Hillaire-Buys, Dominique, Pariente, Antoine, Faillie, Jean-Luc

المساهمون: Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Bordeaux, CHU Montpellier, Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Institut Desbrest de santé publique (IDESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)

المصدر: ISSN: 0149-5992.

مصطلحات موضوعية: MESH: Diabetes Mellitus, Type 2 / diagnosis, MESH: Glucagon-Like Peptide 1 / adverse effects, MESH: Glucagon-Like Peptide-1 Receptor / agonists, MESH: Humans, MESH: Hypoglycemic Agents / adverse effects, MESH: Thyroid Neoplasms / chemically induced, MESH: Thyroid Neoplasms / epidemiology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36356111; hal-03900050; https://hal.science/hal-03900050Test; PUBMED: 36356111

الإتاحة: https://doi.org/10.2337/dc22-1148Test
https://hal.science/hal-03900050Test

المؤلفون: Bezin, Julien, Gouverneur, Amandine, Penichon, Marine, Mathieu, Clement, Garrel, Renaud, Hillaire-Buys, Dominique, Pariente, Antoine, Faillie, Jean-Luc

المساهمون: Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Bordeaux, CHU Montpellier, Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Institut Desbrest de santé publique (IDESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)

المصدر: ISSN: 0149-5992.

مصطلحات موضوعية: MESH: Diabetes Mellitus, Type 2 / diagnosis, MESH: Glucagon-Like Peptide 1 / adverse effects, MESH: Glucagon-Like Peptide-1 Receptor / agonists, MESH: Humans, MESH: Hypoglycemic Agents / adverse effects, MESH: Thyroid Neoplasms / chemically induced, MESH: Thyroid Neoplasms / epidemiology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36356111; hal-03900050; https://hal.science/hal-03900050Test; PUBMED: 36356111

الإتاحة: https://doi.org/10.2337/dc22-1148Test
https://hal.science/hal-03900050Test

المؤلفون: Bezin, Julien, Gouverneur, Amandine, Penichon, Marine, Mathieu, Clement, Garrel, Renaud, Hillaire-Buys, Dominique, Pariente, Antoine, Faillie, Jean-Luc

المساهمون: Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Bordeaux, CHU Montpellier, Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Institut Desbrest de santé publique (IDESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)

المصدر: ISSN: 0149-5992.

مصطلحات موضوعية: MESH: Diabetes Mellitus, Type 2 / diagnosis, MESH: Glucagon-Like Peptide 1 / adverse effects, MESH: Glucagon-Like Peptide-1 Receptor / agonists, MESH: Humans, MESH: Hypoglycemic Agents / adverse effects, MESH: Thyroid Neoplasms / chemically induced, MESH: Thyroid Neoplasms / epidemiology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36356111; hal-03900050; https://hal.science/hal-03900050Test; PUBMED: 36356111

الإتاحة: https://doi.org/10.2337/dc22-1148Test
https://hal.science/hal-03900050Test